-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from 2010 to 2023.
- Acadia Pharmaceuticals Inc Depreciation for the quarter ending March 31, 2024 was $242K, a 43.2% decline year-over-year.
- Acadia Pharmaceuticals Inc annual Depreciation for 2023 was $1.46M, a 28% decline from 2022.
- Acadia Pharmaceuticals Inc annual Depreciation for 2022 was $2.03M, a 9.39% decline from 2021.
- Acadia Pharmaceuticals Inc annual Depreciation for 2021 was $2.24M, a 53.7% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)